These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19597999)

  • 1. Single-chain Fv antibody fragments retain binding properties of the monoclonal antibody raised against peptide P1 of the human prion protein.
    Skrlj N; Serbec VC; Dolinar M
    Appl Biochem Biotechnol; 2010 Mar; 160(6):1808-21. PubMed ID: 19597999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and detection strategies for an scFv fragment retaining the same high affinity than Fab and whole antibody: Implications for therapeutic use in prion diseases.
    Padiolleau-Lefevre S; Alexandrenne C; Dkhissi F; Clement G; Essono S; Blache C; Couraud JY; Wijkhuisen A; Boquet D
    Mol Immunol; 2007 Mar; 44(8):1888-96. PubMed ID: 17140664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
    Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
    Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High level production of functional antibody Fab fragments in an oxidizing bacterial cytoplasm.
    Venturi M; Seifert C; Hunte C
    J Mol Biol; 2002 Jan; 315(1):1-8. PubMed ID: 11771962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
    Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
    J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Light-chain shuffling results in successful phage display selection of functional prokaryotic-expressed antibody fragments to N-glycolyl GM3 ganglioside.
    Rojas G; Talavera A; Munoz Y; Rengifo E; Krengel U; Angström J; Gavilondo J; Moreno E
    J Immunol Methods; 2004 Oct; 293(1-2):71-83. PubMed ID: 15541278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characterization of a panel of mouse single-chain antibodies against recombinant human interferon beta1b].
    Pavlova MV; Nikolaev IuS; Irodov DM; Okunev OV; Kordium VA; Gil'chuk PV
    Tsitol Genet; 2008; 42(4):3-11. PubMed ID: 19140425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human scFvs antibodies recognizing a prion protein epitope expressed on the surface of human lymphoblastoid cells.
    Flego M; Ascione A; Zamboni S; Dupuis ML; Imperiale V; Cianfriglia M
    BMC Biotechnol; 2007 Jul; 7():38. PubMed ID: 17605808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
    Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
    J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular specificities of antibodies against ovine and murine recombinant prion proteins.
    Betemps D; Baron T
    Biochem Biophys Res Commun; 2001 Feb; 281(1):101-8. PubMed ID: 11178966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization of anti-mouse prion peptide single chain Fv antibody by phage display].
    Hachisuka A; Koyano S; Kikuchi Y; Nakajima O; Aosasa M; Matsuda H; Sawada J; Teshima R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2009; (127):26-30. PubMed ID: 20306703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered antibody intervention strategies for Alzheimer's disease and related dementias by targeting amyloid and toxic oligomers.
    Robert R; Dolezal O; Waddington L; Hattarki MK; Cappai R; Masters CL; Hudson PJ; Wark KL
    Protein Eng Des Sel; 2009 Mar; 22(3):199-208. PubMed ID: 18927231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyclonal anti-idiotypic antibodies which mimic an epitope of the human prion protein.
    Hanoux V; Wijkhuisen A; Alexandrenne C; Créminon C; Boquet D; Couraud JY
    Mol Immunol; 2009 Mar; 46(6):1076-83. PubMed ID: 19012967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generating antibodies against the native form of the human prion protein (hPrP) in wild-type animals: a comparison between DNA and protein immunizations.
    Alexandrenne C; Wijkhuisen A; Dkhissi F; Hanoux V; Créminon C; Boquet D; Couraud JY
    J Immunol Methods; 2009 Feb; 341(1-2):41-9. PubMed ID: 19027745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection and characterization of single chain Fv fragments against murine recombinant prion protein from a synthetic human antibody phage display library.
    Leclerc E; Liemann S; Wildegger G; Vetter SW; Nilsson F
    Hum Antibodies; 2000; 9(4):207-14. PubMed ID: 11341174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
    Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
    Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.
    Dincq S; Bosman F; Buyse MA; Degrieck R; Celis L; de Boer M; Van Doorsselaere V; Sablon E
    Protein Expr Purif; 2001 Jun; 22(1):11-24. PubMed ID: 11388794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Directed evolution of an anti-prion protein scFv fragment to an affinity of 1 pM and its structural interpretation.
    Luginbühl B; Kanyo Z; Jones RM; Fletterick RJ; Prusiner SB; Cohen FE; Williamson RA; Burton DR; Plückthun A
    J Mol Biol; 2006 Oct; 363(1):75-97. PubMed ID: 16962610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
    Yang X; Hu W; Li F; Xia H; Zhang Z
    Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.